These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4796782)

  • 1. Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhea-galactorrhea syndrome.
    Zárate A; Canales ES; Soria J; Maneiro PJ; MacGregor C
    Neuroendocrinology; 1973; 12(6):362-5. PubMed ID: 4796782
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of ovarian function in patients with the amenorrhea-galactorrhea syndrome after long-term therapy with L-dopa.
    Zárate A; Canales ES; Jacobs LS; Maneiro PJ; Soria J; Daughaday WH
    Fertil Steril; 1973 May; 24(5):340-4. PubMed ID: 4735421
    [No Abstract]   [Full Text] [Related]  

  • 3. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.
    Zárate A; Jacobs LS; Canales ES; Schally AV; De la Cruz A; Soria J; Daughaday WH
    J Clin Endocrinol Metab; 1973 Dec; 37(6):855-9. PubMed ID: 4584924
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
    Turkington RW
    J Clin Endocrinol Metab; 1972 Feb; 34(2):306-11. PubMed ID: 5062099
    [No Abstract]   [Full Text] [Related]  

  • 7. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
    Turkington RW; Gordon ES
    J Lab Clin Med; 1971 Nov; 78(5):824-5. PubMed ID: 5166936
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactorrhea-amenorrhea due to primary hypothyroidism.
    Boroditsky RS; Faiman C
    Am J Obstet Gynecol; 1973 Jul; 116(5):661-5. PubMed ID: 4713129
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-pill and pill-related amenorrhea-galactorrhea.
    Gambrell RD; Greenblatt RB; Mahesh VB
    Am J Obstet Gynecol; 1971 Jul; 110(6):838-48. PubMed ID: 5562004
    [No Abstract]   [Full Text] [Related]  

  • 12. [FSH and LH plasma levels and their reaction to clomiphene in 3 cases of amenorrhea-galactorrhea syndrome].
    Netter A; Gorins A; Franchimont P; Millet D
    Ann Endocrinol (Paris); 1972; 33(1):53-63. PubMed ID: 4676410
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine effect of L-DOPA in treating the amenorrhea-galactorrhea syndrome].
    Koreneva GP; Shikaeva FV
    Probl Endokrinol (Mosk); 1980; 26(6):25-8. PubMed ID: 7192862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical uses of multiple serum FSH and LH measurements in patients with amenorrhea and infertility.
    Friedman S
    Obstet Gynecol; 1973 Jun; 41(6):809-17. PubMed ID: 4736128
    [No Abstract]   [Full Text] [Related]  

  • 17. [The values of prelactin, FSH and LH in the course of galactorrhoea (author's transl)].
    Stehlíková J; Talas M; Fingerová H
    Cesk Gynekol; 1975 Sep; 40(8):603-5. PubMed ID: 1238174
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of L-dopa on galactopoiesis and gonadotropin levels in the inappropriate lactation syndrome.
    Ayalon D; Peyser MR; Toaff R; Cordova T; Harell A; Franchimont P; Lindner HR
    Obstet Gynecol; 1974 Aug; 44(2):159-70. PubMed ID: 4418555
    [No Abstract]   [Full Text] [Related]  

  • 19. Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.
    Beumont P; Bruwer J; Pimstone B; Vinik A; Utian W
    Br J Psychiatry; 1975 Mar; 126():285-8. PubMed ID: 236061
    [No Abstract]   [Full Text] [Related]  

  • 20. [Response to the treatment of non-puerperal galactorrhea with dihydroergotoxine (author's transl)].
    Zielinski de Jakubowicz D; Obregón O
    Acta Cient Venez; 1979; 30(1):98-104. PubMed ID: 121905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.